Darbepoetin biosimilar (Hetero Biopharma)
N/A
Report date: 2025/01/17 17:55:37
Base Information
Drug NameDarbepoetin biosimilar (Hetero Biopharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHetero Biopharma Ltd
China Registration ClassN/A
Develop Information
Active CompaniesPSK Pharma LLCHetero Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A